Source: NEWSOK

Dezima Pharma: Amgen buys 1 company, partners with 2nd to create new drugs

TRENTON, N.J. (AP) - Biotech drug giant Amgen is making deals to replenish its stock of medicines in development as new competition to its lucrative biotech drugs threatens future revenue.The world's biggest biotech drugmaker is buying one company with a daily cholesterol treatment in mid-stage patient testing.Read more on

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Rob de Ree's photo - CEO of Dezima Pharma


Rob de Ree

CEO Approval Rating


Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia.

Read more